News | April 02, 2024
Apotex to acquire Canadian Searchlight Pharma
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
Combination will create a Canadian Health Champion spanning generic, biosimilar and branded pharmaceuticals
This acquisition enables MTD to open new, strategic markets
Asahi Songwon Colors' shareholding in ALSPL has increased from 78% to 100%
To accelerate the development of next-generation radioconjugates to treat cancer
Lonza plans to invest approximately CHF 500 million to upgrade the facility
Acquisition to further expand the Alexion, AstraZeneca Rare Disease pipeline beyond complement inhibition
Both organisations enter into a long- term collaboration to expand patient access in India
Completes acquisition of 75% of share capital from Glenmark Pharmaceuticals
Arun is currently working as Vice President (Strategy) in Solara leading Business finance & Strategy function
The plan is to set up an ultramodern Solvent Recovery Plant for third party purposes
Subscribe To Our Newsletter & Stay Updated
